Form 4 holding
General Counsel
Eiger BioPharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 120,000
- Estimated value
- Report date
- 30 Apr 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount